Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial

Journal of Clinical Oncology - United States
doi 10.1200/jco.2005.01.180
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

High-Dose Epirubicin Is Not an Alternative to Standard-Dose Doxorubicin in the Treatment of Advanced Soft Tissue Sarcomas. A Study of the EORTC Soft Tissue and Bone Sarcoma Group

British Journal of Cancer
Cancer ResearchOncology
1998English

Treatment of Pelvic Bone and Soft Tissue Sarcoma.

Orthopedics & Traumatology
1997English

Pediatric Bone and Soft-Tissue Sarcomas

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2015English

A Randomised Phase II Trial of Selumetinib vs Selumetinib Plus Temsirolimus for Soft-Tissue Sarcomas

British Journal of Cancer
Cancer ResearchOncology
2015English

Predictive and Prognostic Factors Associated With Soft Tissue Sarcoma Response to Chemotherapy: A Subgroup Analysis of the European Organisation for Research and Treatment of Cancer 62012 Study

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2017English

Gemcitabine and Docetaxel Combination Chemotherapy for Advanced Bone and Soft Tissue Sarcomas: Protocol for an Open-Label, Non-Randomised, Phase 2 Study

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Guidelines for the Management of Soft Tissue Sarcomas

Sarcoma
Nuclear MedicineRadiologyImagingOncology
2010English

Update on Systemic Therapy for Advanced Soft Tissue Sarcoma

Current Oncology
Oncology
2020English

Feasibility of Chemotherapy in Treatment of Adult Soft Tissue Sarcomas

Orthopedics & Traumatology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy